Author

Michael Russell Bishop

University of ChicagoORCID 0000-0002-3979-9273Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Erting TangiD· 2 shared Guoshuai CaoiD· 2 shared Jun HuangiD· 2 shared Justin Paul KlineiD· 2 shared Nicholas W. AsbyiD· 2 shared Peter A. RiedelliD· 2 shared Yifei HuiD· 2 shared Duy-Thuc NguyeniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Erting TangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Low-Strength Type I Interferon Signaling Promotes CAR T-Cell Treatment Efficacy

Erting Tang, Yifei Hu, Guoshuai Cao, Duy-Thuc Nguyen, Nicholas W. Asby, Nada S. Aboelella, Hanna A. Ruiz, Xiaolei Cai, Wenbo Zhang, Yu Qing Zhao, Lishi Xie, Xiufen Chen, Michael Russell Bishop, Peter A. Riedell, James L. LaBelle, , Jun Huang

This study shows that low-strength type I interferon signaling enhances CAR T-cell efficacy against B-cell lymphoma and leukemia without causing in vivo toxicity.

Cancer Immunology Research · May 8, 2026Peer-reviewedImmunology

Two-Stage CD8+ CAR T-Cell Differentiation in Patients with Large B-Cell Lymphoma

Guoshuai Cao, Yifei Hu, Tony Pan, Erting Tang, Nicholas W. Asby, Thomas Althaus, Jun Wan, Peter A. Riedell, Michael Russell Bishop, Justin Paul Kline, Jun Huang

This study identifies two distinct waves of CD8+ CAR T-cell differentiation in DLBCL patients, showing they originate from different precursor populations with distinct phenotypes and ontogenies.

Nature Communications · May 6, 2025Peer-reviewedImmunology